New Logo July 12, 2022.png
Odyssey Health, Inc. Makes Statement Regarding its Concussion Drug Development Program
30 sept. 2022 18h28 HE | Odyssey Health, Inc
Las Vegas Nevada, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., (the “Company” “Odyssey”) a company focused on developing a unique...
Insights on the Trauma Care Centers Global Market to 2030 - Increasing Number of Trauma Care Centers is Driving Growth
29 sept. 2022 06h33 HE | Research and Markets
Dublin, Sept. 29, 2022 (GLOBE NEWSWIRE) -- The "Trauma Care Centers Market Size, Share & Trends Analysis Report by Facility Type (In-house, Standalone), by Trauma Type (Falls, Traffic-related...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore Strengthens Patent Portfolio with Issuance of Four New U.S. Patents
21 sept. 2022 08h00 HE | electroCore, Inc.
ROCKAWAY, N.J., Sept. 21, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the United States Patent and Trademark...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
Electrocore Announces Date for Fiscal Year 2022 Annual Meeting and Deadlines for Stockholder Proposals
20 sept. 2022 08h00 HE | electroCore, Inc.
ROCKAWAY, N.J., Sept. 20, 2022 (GLOBE NEWSWIRE) --  electroCore, Inc. (Nasdaq: ECOR) (the “Company”), a commercial-stage bioelectronic medicine company, today announced its plans to hold its fiscal...
New Logo July 12, 2022.png
Odyssey Health Achieves Positive Safety Outcomes for Concussion Drug in Multiple Ascending Dosing Trial, Cohort II
13 sept. 2022 08h00 HE | Odyssey Health, Inc
Las Vegas, NV, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products,...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
gammaCore (Non-Invasive Vagus Nerve Stimulation; nVNS) Reduces Symptoms of Acute Withdrawal in Patients with Opioid Use Disorder
07 sept. 2022 08h00 HE | electroCore, Inc.
ROCKAWAY, N.J., Sept. 07, 2022 (GLOBE NEWSWIRE) --  electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the publication of a peer reviewed...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore to Participate at Upcoming Investor Conferences
06 sept. 2022 08h00 HE | electroCore, Inc.
ROCKAWAY, N.J., Sept. 06, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that electroCore’s Chief Executive Officer,...
New Logo July 12, 2022.png
Odyssey Health, Inc. Announces Positive Results from Its Phase I Multi-Day Ascending Dosing for the Treatment of Concussion
10 août 2022 08h00 HE | Odyssey Health, Inc
Las Vegas, NV, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-improving medical products,...
Steven M. Oser, P.C. Logo.png
Steven M. Oser P.C Launches Car Accident Awareness Campaign: Helping Auto Injury Victims Seek Compensation
08 août 2022 09h00 HE | Steven M. Oser, P.C.
Suffolk, VA, Aug. 08, 2022 (GLOBE NEWSWIRE) -- The most recent Commonwealth of Virginia research into automobile accidents exposed some worrying truths. In 2020, the number of motor vehicle...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore to Participate at Canaccord Genuity 42nd Annual Growth Conference
05 août 2022 08h00 HE | electroCore, Inc.
ROCKAWAY, N.J., Aug. 05, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that electroCore’s Chief Executive Officer, Dan...